- Home
- LNSR vs CLSD Comparison
LNSR vs CLSD Comparison
Compare LNSR & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- CLSD
- Stock Information
- Founded
- LNSR 2004
- CLSD 2011
- Country
- LNSR United States
- CLSD United States
- Employees
- LNSR N/A
- CLSD N/A
- Industry
- LNSR Medical Electronics
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- LNSR Health Care
- CLSD Health Care
- Exchange
- LNSR Nasdaq
- CLSD Nasdaq
- Market Cap
- LNSR 63.4M
- CLSD 74.3M
- IPO Year
- LNSR N/A
- CLSD 2016
- Fundamental
- Price
- LNSR $8.32
- CLSD $0.93
- Analyst Decision
- LNSR
- CLSD Strong Buy
- Analyst Count
- LNSR 0
- CLSD 6
- Target Price
- LNSR N/A
- CLSD $5.33
- AVG Volume (30 Days)
- LNSR 52.9K
- CLSD 301.0K
- Earning Date
- LNSR 03-03-2025
- CLSD 03-11-2025
- Dividend Yield
- LNSR N/A
- CLSD N/A
- EPS Growth
- LNSR N/A
- CLSD N/A
- EPS
- LNSR N/A
- CLSD N/A
- Revenue
- LNSR $48,868,000.00
- CLSD $7,703,000.00
- Revenue This Year
- LNSR $25.07
- CLSD N/A
- Revenue Next Year
- LNSR $24.95
- CLSD $91.87
- P/E Ratio
- LNSR N/A
- CLSD N/A
- Revenue Growth
- LNSR 21.29
- CLSD 248.39
- 52 Week Low
- LNSR $2.67
- CLSD $0.80
- 52 Week High
- LNSR $9.23
- CLSD $2.12
- Technical
- Relative Strength Index (RSI)
- LNSR 53.60
- CLSD 42.76
- Support Level
- LNSR $7.25
- CLSD $0.90
- Resistance Level
- LNSR $9.13
- CLSD $0.97
- Average True Range (ATR)
- LNSR 0.63
- CLSD 0.05
- MACD
- LNSR -0.07
- CLSD 0.00
- Stochastic Oscillator
- LNSR 56.61
- CLSD 24.29
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.